Kernal is creating mRNA therapies that instruct specific cells on how to make their own drugs to cure an illness. Today, we are targeting COVID-19 and cancer, but this technique can be used for a number of other illnesses, too. With roots at MIT, Harvard and Bio Pharma, the team previously built a successful Biotech company and has deep technical expertise in mRNA space.
Ja – Kernal Biologics, Inc. hat aktuell 3 offene Stellen auf JobsRadar. 1 davon wurden in den letzten 30 Tagen ausgeschrieben. Zuletzt aktualisiert am 17. September 2026 um 11:15 UTC.